Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Implications of m6A modification in autoimmune disorders.

× No keyword cloud information.

1 in total

1. A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE.

Authors: Xingqiang Wang; Dongyun Lei; Jie Ding; Shuang Liu; Li Tao; Fan Zhang; Jiangyun Peng; Jian Xu
Journal: J Immunol Res Date: 2018-08-12 Impact factor: 4.818

1 in total

6 in total

1. Fumonisin B₁ alters global m6A RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cells.

Authors: Thilona Arumugam; Terisha Ghazi; Anil A Chuturgoon
Journal: Arch Toxicol Date: 2021-01-26 Impact factor: 5.153

2. METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m⁶A-dependent manner.

Authors: Jiayu Meng; Xianyang Liu; Shiyun Tang; Yusen Liu; Chenyang Zhao; Qian Zhou; Na Li; Shengping Hou
Journal: Front Immunol Date: 2022-07-21 Impact factor: 8.786

3. Identification of molecular patterns and diagnostic biomarkers in juvenile idiopathic arthritis based on the gene expression of m⁶A regulators.

Authors: Shibo Zhang; Jing Qin; Yuechao Zhao; Jian Wang; Zhiliang Tian
Journal: Front Pediatr Date: 2022-09-08 Impact factor: 3.569

Implications of m6A modification in autoimmune disorders.

1. A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE.

1. Fumonisin B₁ alters global m6A RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cells.

2. METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m⁶A-dependent manner.

3. Identification of molecular patterns and diagnostic biomarkers in juvenile idiopathic arthritis based on the gene expression of m⁶A regulators.

4. m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent.

Review 5. From A to m⁶A: The Emerging Viral Epitranscriptome.

Review 6. m6A RNA Methylation in Systemic Autoimmune Diseases-A New Target for Epigenetic-Based Therapy?

Implications of m6A modification in autoimmune disorders.

1. A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE.

1. Fumonisin B1 alters global m6A RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cells.

2. METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner.

3. Identification of molecular patterns and diagnostic biomarkers in juvenile idiopathic arthritis based on the gene expression of m6A regulators.

4. m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent.

Review 5. From A to m6A: The Emerging Viral Epitranscriptome.

Review 6. m6A RNA Methylation in Systemic Autoimmune Diseases-A New Target for Epigenetic-Based Therapy?

1. Fumonisin B₁ alters global m6A RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cells.

2. METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m⁶A-dependent manner.

3. Identification of molecular patterns and diagnostic biomarkers in juvenile idiopathic arthritis based on the gene expression of m⁶A regulators.

Review 5. From A to m⁶A: The Emerging Viral Epitranscriptome.